文献速递心胸血管麻醉术前评估与围术期医学

右心室-肺动脉耦联比值与心脏手术后主要并发症及手术死亡率的关系

Right Ventricle-Pulmonary Artery Coupling and Major Morbidity and Operative Mortality After Cardiac Surgery.
PubMed 文献 · Anesth Analg · 2025-06-12

该回顾性队列研究纳入868例接受冠状动脉旁路移植和/或瓣膜手术的成人患者,以TAPSE/PASP比值评估右心室-肺动脉耦联。

要点

  • 术前TAPSE/PASP比值<0.52 mm/mm Hg与心脏手术后MMOM风险增加独立相关。
  • TAPSE/PASP比值每增加0.1 mm/mm Hg,ICU停留时间和机械通气时间减少4%,住院时间减少3%。

核心结论

  • 术前TAPSE/PASP比值<0.52 mm/mm Hg与心脏手术后主要并发症及手术死亡率风险显著增加独立相关。
  • 低术前TAPSE/PASP比值还与更长的ICU停留时间、住院时间和机械通气时间相关,即使调整STS风险评分和体外循环时间后仍显著。

研究设计与样本

  • 回顾性队列研究,纳入868例接受冠状动脉旁路移植和/或瓣膜手术(主动脉瓣、二尖瓣、三尖瓣)的成人患者。
  • RV-PA比值通过三尖瓣环收缩期位移(TAPSE)与肺动脉收缩压(PASP)的比值计算。
  • 主要结局为胸外科医师学会(STS)定义的MMOM;采用Youden指数确定TAPSE/PASP比值的最佳截断值,并进行多变量分析。

主要发现

  • TAPSE/PASP比值每增加0.1 mm/mm Hg,ICU停留时间和机械通气时间减少4%,住院时间减少3%。

关键数值与推荐

  • TAPSE/PASP比值每增加0.1 mm/mm Hg,ICU停留时间和机械通气时间减少4%,住院时间减少3%。

临床怎么用

  • 对于接受冠状动脉旁路移植和/或瓣膜手术的成人患者,术前可考虑计算TAPSE/PASP比值以评估右心室-肺动脉耦联。
  • 术前TAPSE/PASP比值<0.52 mm/mm Hg提示MMOM风险增加,可辅助围术期风险分层和资源分配。
  • 低TAPSE/PASP比值患者可能受益于更密切的术后监护和延长机械通气支持的计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The right ventricle-pulmonary artery (RV-PA) coupling ratio provides an assessment of RV function indexed to PA afterload. A low preoperative RV-PA ratio has been associated with increased mortality after transcatheter procedures. In patients undergoing cardiac surgery, we hypothesized that a lower preoperative RV-PA ratio is independently associated with a higher risk of major morbidity and operative mortality (MMOM). METHODS: We conducted a retrospective cohort study of adult patients who underwent coronary artery bypass graft and/or valve surgery (aortic, mitral, and tricuspid). The RV-PA ratio was calculated using the ratio of tricuspid annular plane systolic excursion (TAPSE) to PA systolic pressure (PASP). The primary outcome was MMOM as defined by the Society of Thoracic Surgeons (STS). The Youden index was used to determine the optimal cutoff to classify into low versus high TAPSE/PASP ratio groups. Multivariable analysis was performed to test the association of TAPSE/PASP ratio with MMOM and other clinical outcomes with P- value <0.05 used for statistical significance. RESULTS: One hundred and twenty-four (14.3%) of the 868 patients who met inclusion criteria had the primary outcome of MMOM. Patients in the low TAPSE/PASP group were more likely to have MMOM (90 (22.0%) vs 34 (7.4%); P < .001) as well as longer intensive care unit length of stay (ICU-LOS), hospital LOS (H-LOS), and mechanical ventilation time (MVT). By multivariable analysis, TAPSE/PASP ratio <0.52 mm/mm Hg was associated with a significant increase in the risk of MMOM (odds ratio [OR] 1.77, 95% confidence interval [CI], 1.10-2.83, P = .018). In the analyses of secondary outcomes, for every 0.1 mm/mm Hg increase in TAPSE/PASP ratio, there was a 4% reduction in ICU-LOS and MVT, and a 3% reduction in H-LOS. CONCLUSIONS: TAPSE/PASP ratio <0.52 mm/mm Hg was associated with a significant increase in the risk of MMOM. Low preoperative TAPSE/PASP ratio was also associated with longer ICU-LOS, H-LOS, and MVT, even when adjusting for STS risk score for MMOM and cardiopulmonary bypass time.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Sun KW, Li YJ, Huang H, et al. Right Ventricle-Pulmonary Artery Coupling and Major Morbidity and Operative Mortality After Cardiac Surgery. Anesth Analg. 2025. PMID: 40505025. doi:10.1213/ANE.0000000000007582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。